| |
| |
|
| Insider
Information: |
Vakiener Victoria |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
84,686 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$785,309 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
84,686 |
|
|
| Total
Value |
$785,309 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Epizyme, Inc. |
EPZM |
Chief Commercial Officer |
2021-02-04 |
52,685 |
|
0 |
Premium* |
|
|
Arrowhead Pharmaceuticals Inc |
ARWR |
Director |
2024-01-11 |
32,001 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2024-01-11 |
4 |
AS |
$37.87 |
$179,813 |
D/D |
(4,720) |
32,001 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2023-12-15 |
4 |
A |
$25.41 |
$380,820 |
D/D |
14,987 |
36,721 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2023-09-28 |
4 |
S |
$26.33 |
$40,812 |
D/D |
(1,550) |
21,734 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2023-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,867 |
23,284 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2023-01-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,764) |
15,417 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2022-05-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
17,181 |
|
% |
|
| EPZM |
Epizyme, Inc. |
Chief Commercial Officer |
• – – |
2021-02-04 |
4 |
AS |
$11.21 |
$9,159 |
D/D |
(817) |
52,685 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
Chief Commercial Officer |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,520 |
53,502 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Chief Commercial Officer |
• – – |
2021-01-25 |
4 |
AS |
$11.41 |
$6,835 |
D/D |
(599) |
27,982 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
Chief Commercial OfficerOffice |
• – – |
2020-09-18 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
28,581 |
|
- |
|
| EPZM |
Epizyme, Inc. |
Chief Commercial OfficerOffice |
• – – |
2020-09-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
26,867 |
|
% |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
